Abstract
Introduction: Hepatorenal syndrome (HRS) is the development of renal failure in patients with severe liver disease. Acute renal dysfunction including HRS is commonly occurs in hospitalized patients with cirrhosis. It is observed that morbidity and mortality remain high once the syndrome is established. This syndrome is usually managed with different vasoconstrictors and albumin with variable outcome but ultimate treatment is the liver transplantation. Methodology: This was a hospital based descriptive study carried out in Liver unit of Bir hospital. The cases were collected from (April, 2015 to March, 2016), admitted in Liver unit, Bir Hospital, Kathmandu, Nepal. One hundred and thirty eight cases were randomly selected from 450 patients admitted in the hospital.Patients of HRS were selected and treated with one of the treatment regime from 1. Albumin and Nor adrenaline group 2. Albumin and Dopamine group 3. Dopamine only 4.Terlipressin and Albumin groups. Patients with No HRS group were treated according to standard protocol of the institute.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Gastroenterology & Hepatology Reports
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
